Study Design and Baseline Characteristics of the VERINA Study: Phase IV Evidence of Vericiguat for Worsening Heart Failure Management
20250 citationsJournal Articlegold Open Access
Field-Weighted Citation Impact: 0.00
Study Design and Baseline Characteristics of the VERINA Study: Phase IV Evidence of Vericiguat for Worsening Heart Failure Management | Researchclopedia